Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
INFILTHERA: Pudendal Nerve Infiltrations for Pudendal Neuralgia
NCT00851513Phase 4Completed
- Sponsor
- CHU de Nantes
- Start
- Nov 2008
- Primary completion
- Feb 2011
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 4, randomised trial of methylprednisolone in pudendal neuralgia (PN) (3 arms), sponsored by CHU de Nantes. Primary endpoint: Therapeutical efficacy on pain at 3 months. Started Nov 2008; status: completed.
02
Drugs
methylprednisolone
03
Conditions
pudendal neuralgia (PN)
Beyond the preview
Go deeper on NCT00851513.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00851513.